Testing effectiveness (Phase 2)WithdrawnNCT00746980What this trial is testingEfalizumab in the Treatment of Alopecia, Phase IIWho this might be right forAlopecia Totalis Northwestern University
Post-approval studies (Phase 4)Looking for participantsNCT07381556What this trial is testingCyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness StudyWho this might be right forAlopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/Universalis+3 more Erasmus Medical Center 50
Not applicableAvailableNCT05522556What this trial is testingPre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Who this might be right forAlopecia Areata Pfizer
Large-scale testing (Phase 3)Looking for participantsNCT06873945What this trial is testing2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataWho this might be right forAlopecia Areata Pfizer 550
Not applicableStudy completedNCT05098600What this trial is testingThe Epidemiology, Management and Comorbidities in Alopecia Areata in Czech RepublicWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis+24 more Faculty Hospital Kralovske Vinohrady 123